Vaxcyte, Inc.
PCVX
Paul Sauer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Paul Sauer
The proxy statement of Vaxcyte, Inc. reports total compensation of $2,354,242 for Paul Sauer in fiscal 2022, including a base salary of $390,938. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Vaxcyte, Inc. (PCVX)
Proxy statement
Start not stated–2023-04-28
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Vaxcyte, Inc. (PCVX) | Senior Vice President, Process Development and Manufacturing | $390,938 | $2,354,242 |
| 2021 | Vaxcyte, Inc. (PCVX) | Senior Vice President, Process Development and Manufacturing | $375,000 | $1,087,630 |
| 2020 | Vaxcyte, Inc. (PCVX) | Senior Vice President, Process Development and Manufacturing | $310,500 | $904,518 |
Recent activity
No call appearances or filed executive changes recorded yet.